Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs helps you conquer the complexities of antibody development and streamline your path to market. Our advanced antibody glycosylation analysis services provide the critical insights needed to ensure the quality, safety, and efficacy of your therapeutic products, accelerating drug discovery and optimizing the development of high-quality recombinant proteins.
Glycosylation, a critical post-translational modification, profoundly influences an antibody's function, stability, and therapeutic efficacy. As the biopharmaceutical industry increasingly relies on monoclonal antibodies (mAbs) for disease treatment, understanding and controlling their glycosylation is paramount. The heterogeneity of glycan structures can alter an antibody's half-life, solubility, and its ability to elicit an immune response, such as antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). The development of this analysis is essential to ensure that therapeutic antibodies are both safe and effective. As gene therapy technologies advance to encode for therapeutic protein expression in vivo, robust quality control of the resulting expressed protein—including its glycosylation profile—is a critical next step. This ensures that the gene therapy product translates into a functional, non-toxic, and therapeutically viable protein, underscoring the necessity and significance of this analysis in the broader field of therapeutic development.
Fig.1 The structure of human IgG and glycan composition.1
Confronting the challenges of glycan heterogeneity is paramount for successful therapeutic development. Our antibody glycosylation analysis service is designed to tackle these complexities head-on. By providing precise, reliable data, we empower you to ensure your final product meets the highest standards for quality and regulatory approval. Our approach is grounded in three core principles: Precision, Efficiency, and Quality Assurance. Through a comprehensive, customizable workflow and dedicated scientific support, we deliver the detailed insights needed for confident decision-making, while maintaining a typical turnaround of 4-8 weeks depending on project scope.
Creative Biolabs offers a tiered approach to antibody glycosylation analysis to meet diverse research and development needs.
This service quantifies the amounts of individual monosaccharides such as fucose, galactose, and mannose. By analyzing the composition of these building blocks, we can screen for compositional changes in your glycosylation profile relative to a reference protein, which provides a fast and effective way to monitor consistency.
Learn More →Glycan analysis is a powerful tool for monitoring the relative quantities of a specific set of glycans and identifying any aberrant structures. We enzymatically release the N-linked glycans from the protein to ensure accurate structural analysis. These released oligosaccharides are then analyzed using advanced methods such as mass spectrometry (MS) and high-performance liquid chromatography (HPLC) to provide valuable information on your glycan patterns.
Learn More →Our Glycosylation Site Profiling service goes beyond a general overview to provide a deeper understanding of your antibody. By profiling glycans at the peptide level, we can achieve relative quantification for specific glycosylation sites. This is crucial for understanding how the location of a glycan affects an antibody's function and stability.
Learn More →Intact Glycoprotein Profiling uses mass spectrometry (MS) to analyze the expected pattern and degree of glycosylation on the complete protein molecule. This method is ideal for assessing the overall glycosylation heterogeneity and provides a holistic view without the need for complex glycan release. The use of ESI-MS allows us to place multiple charges on each species, enabling high-resolution analysis of the full glycoform profile with high sensitivity.
Learn More →This service provides a comprehensive snapshot of the total glycan population present on your therapeutic antibody. By enzymatically releasing N- or O-glycans from the protein backbone and analyzing them via high-performance techniques, we generate a detailed profile of all glycan classes, including high-mannose, complex, and hybrid types.
Learn More →This service delivers a precise map of which glycan structures are attached to each individual glycosylation site on your antibody. Utilizing advanced technology, we analyze intact glycopeptides to correlate specific sugar chains with their exact amino acid locations. This site-specific information is vital for understanding how glycosylation at particular positions impacts conformation, Fc receptor binding, and overall therapeutic efficacy, enabling more targeted quality control and molecular design.
Learn More →This service bridges the gap between glycan structure and biological function. We combine detailed glycosylation analysis with parallel functional bioassays to identify specific glycan features that drive therapeutic activity. By applying statistical correlation models, we help you pinpoint critical quality attributes that most significantly influence efficacy or safety.
Learn More →This service offers an integrated, high-resolution characterization of all glycan-related attributes on your therapeutic candidate. Going beyond simple profiling, we provide an in-depth structural elucidation of both major and minor glycan species, including the identification of sialylated, fucosylated, and afucosylated variants.
Learn More →A1: Glycosylation is a critical quality attribute (CQA) that impacts an antibody's stability, half-life, and effector functions. Analyzing glycosylation patterns is essential for ensuring your therapeutic antibody is safe and effective for its intended application, and is often a regulatory requirement.
A2: The primary difference lies in where the sugar is attached. N-glycans are linked to the nitrogen of an asparagine residue, while O-glycans are attached to the oxygen of a serine or threonine residue. Our services can analyze both, but N-glycan analysis is typically more common for therapeutic antibodies.
A3: You will receive a detailed report with a complete glycan profile, including the relative abundance of each glycoform, as well as a list of identified glycan structures. This data provides a clear picture of your antibody's glycosylation status.
A4: Glycosylation can be influenced by bioprocess conditions. While a full analysis may not be needed for every single batch, it is highly recommended to perform it for early-stage development, bioprocess optimization, and for all lots intended for clinical trials to ensure consistency and compliance.
To complement your therapeutic antibody project, we offer several other services you might find useful.
Creative Biolabs is your expert partner in antibody glycosylation analysis, offering comprehensive solutions that accelerate your drug development pipeline and ensure the quality and safety of your biopharmaceutical products. Our services, backed by advanced technology and deep scientific expertise, provide the critical insights needed to navigate the complexities of glycobiology. For a detailed discussion about your specific needs or to receive a quote, please reach out to us. We look forward to partnering with you on your next breakthrough.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
